Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    -24.00 (-1.88%)
Bid:
1,246.00
Ask:
1,258.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

7 Oct 2025 15:15

RNS Number : 4303C
Cohort PLC
07 October 2025
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

7 October 2025

 

 

 

COHORT PLC

("Cohort" or "the Company")

 

Director Shareholdings

 

The Company announces that, following payment of the Company's interim dividend on 3 October 2025, dividends received in respect of ordinary shares of 10 pence each in the Company ("Shares") held by Andrew Thomis, Chief Executive and Simon Walther, Finance Director were automatically reinvested and the shares purchased have now been notified to the individuals as follows:

 

Director/PCA

Date

Account

No. of shares

Price per Share

Andrew Thomis, Chief Executive

 

06/10/2025

Share Incentive Plan

19

1396p

06/10/2025

Global Nominee

49

1379.36p

 

Simon Walther, Finance Director

06/10/2025

Share Incentive Plan

19

1396p

06/10/2025

Global Nominee

12

1379.36p

07/10/2025

ISA

5

1386.4p

 

As a result of the above transactions, the beneficial interest in Shares of Andrew Thomis is 186,411, representing 0.40% of the total issued share capital of the Company and the beneficial interest in Shares of Simon Walther is 149,614, representing 0.32% of the total issued share capital of the Company.

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.

 

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Thomis

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cohort plc

b)

Legal Entity Identifier Code

213800WE61C73LZZNW11

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares in Cohort plc with a nominal value of 10 pence each

b)

Identification Code

GB00B0YD2B94

c)

Nature of the transaction

Automatic reinvestment of dividends received on ordinary shares held in a SIP account

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

19 shares at 1396.0p

49 shares at 1379.36p

f)

Aggregated Information

- Price

- Volume

- Total

 

1384.01p

68

£941.13

g)

Date of transaction

6 October 2025

h)

Place of transaction

London Stock Exchange AIM

 

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Simon Walther

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cohort plc

b)

Legal Entity Identifier Code

213800WE61C73LZZNW11

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares in Cohort plc with a nominal value of 10 pence each

b)

Identification Code

GB00B0YD2B94

c)

Nature of the transaction

Automatic reinvestment of dividends received on ordinary shares held in SIP and ISA accounts

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

19 shares at 1396.00p

12 shares at 1379.36p

5 shares at 1386.4p

f)

Aggregated Information

- Price

- Volume

- Total

 

1389.12p

36

£500.08

g)

Date of transaction

6 and 7 October 2025

h)

Place of transaction

London Stock Exchange AIM

 

 

ENDS

 

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

Kellie Young, Group Head of Investor Communications and Events

 

 

 

Investec Bank Plc (Financial Adviser, Nominated Adviser, and Corporate Broker)

020 7597 5970

Carlton Nelson, Christopher Baird, Charlotte Young

 

 

 

MHP

07817 458804

Reg Hoare, Ollie Hoare, Hugo Harris

cohort@mhpgroup.com

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,500 core staff there and at its other operating company sites across the UK, Australia Germany, and Portugal.

 

The group is split into two segments - Communications and Intelligence, and Sensors and Effectors:

 

Communications and Intelligence

 

· EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

 

· EM Solutions designs, assembles, tests, and supports satellite communications on-the-move terminals for defence and government customers. It also provides high-end broadband radio transceivers and other RF Subsystems such as low noise receivers and solid-state high-power transmitters for defence and commercial customers. Acquired by Cohort in January 2025. www.emsolutions.com.au

 

· MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services, and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

· MCL designs, sources, and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

Sensors and Effectors

 

· Chess Dynamics offers surveillance, tracking and fire-control systems to the defence and security markets. Chess has been part of the Group since December 2018. www.chess-dynamics.com

 

· ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

 

· SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSBDGXBGDGUR
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.